Evaluation and treatment of respiratory alkalosis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Respiratory alkalosis is the most frequent acid-base disturbance encountered in clinical practice. This is particularly true in critically ill patients, for whom the degree of hypocapnia directly correlates with adverse outcomes. Although this acid-base disturbance often is considered benign, evidence suggests that the alkalemia of primary hypocapnia can cause clinically significant decreases in tissue oxygen delivery. Mild respiratory alkalosis often serves as a marker of an underlying disease and may not require therapeutic intervention. In contrast, severe respiratory alkalosis should be approached with a sense of urgency and be aggressively corrected.

Original languageEnglish (US)
Pages (from-to)834-838
Number of pages5
JournalAmerican Journal of Kidney Diseases
Volume60
Issue number5
DOIs
StatePublished - Nov 2012

Fingerprint

Respiratory Alkalosis
Hypocapnia
Acids
Critical Illness
Therapeutics
Oxygen

Keywords

  • alkalemia
  • hyperventilation
  • hypocapnia
  • Respiratory alkalosis

ASJC Scopus subject areas

  • Nephrology

Cite this

Evaluation and treatment of respiratory alkalosis. / Palmer, Biff F.

In: American Journal of Kidney Diseases, Vol. 60, No. 5, 11.2012, p. 834-838.

Research output: Contribution to journalArticle

@article{8069b1fe0d414f08a8da7c66014ffd3f,
title = "Evaluation and treatment of respiratory alkalosis",
abstract = "Respiratory alkalosis is the most frequent acid-base disturbance encountered in clinical practice. This is particularly true in critically ill patients, for whom the degree of hypocapnia directly correlates with adverse outcomes. Although this acid-base disturbance often is considered benign, evidence suggests that the alkalemia of primary hypocapnia can cause clinically significant decreases in tissue oxygen delivery. Mild respiratory alkalosis often serves as a marker of an underlying disease and may not require therapeutic intervention. In contrast, severe respiratory alkalosis should be approached with a sense of urgency and be aggressively corrected.",
keywords = "alkalemia, hyperventilation, hypocapnia, Respiratory alkalosis",
author = "Palmer, {Biff F.}",
year = "2012",
month = "11",
doi = "10.1053/j.ajkd.2012.03.025",
language = "English (US)",
volume = "60",
pages = "834--838",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Evaluation and treatment of respiratory alkalosis

AU - Palmer, Biff F.

PY - 2012/11

Y1 - 2012/11

N2 - Respiratory alkalosis is the most frequent acid-base disturbance encountered in clinical practice. This is particularly true in critically ill patients, for whom the degree of hypocapnia directly correlates with adverse outcomes. Although this acid-base disturbance often is considered benign, evidence suggests that the alkalemia of primary hypocapnia can cause clinically significant decreases in tissue oxygen delivery. Mild respiratory alkalosis often serves as a marker of an underlying disease and may not require therapeutic intervention. In contrast, severe respiratory alkalosis should be approached with a sense of urgency and be aggressively corrected.

AB - Respiratory alkalosis is the most frequent acid-base disturbance encountered in clinical practice. This is particularly true in critically ill patients, for whom the degree of hypocapnia directly correlates with adverse outcomes. Although this acid-base disturbance often is considered benign, evidence suggests that the alkalemia of primary hypocapnia can cause clinically significant decreases in tissue oxygen delivery. Mild respiratory alkalosis often serves as a marker of an underlying disease and may not require therapeutic intervention. In contrast, severe respiratory alkalosis should be approached with a sense of urgency and be aggressively corrected.

KW - alkalemia

KW - hyperventilation

KW - hypocapnia

KW - Respiratory alkalosis

UR - http://www.scopus.com/inward/record.url?scp=84867577930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867577930&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2012.03.025

DO - 10.1053/j.ajkd.2012.03.025

M3 - Article

C2 - 22871240

AN - SCOPUS:84867577930

VL - 60

SP - 834

EP - 838

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -